Activate map
Yes |
Specialties
Jerome Goldstein, M.D. is a Board-certified medical neurologist who has a special interest in the diagnosis, treatment, and prevention of headaches.
Dr. Goldstein graduated from the Upstate Medical Center in Syracuse, New York and completed his Neurology residency at the University of California in San Francisco in 1970. He is certified by the American Board of Psychiatry and Neurology and is the Director of the San Francisco Clinical Research Center as well as a member of The American Headache Society, The International Headache Society, and The National Headache Foundation.
Dr. Goldstein has directed research studies on every new 5-HT 1D receptor agonists, including the original pilot studies done on Imitrex® in the United States, including all new prophylactic agents in headache and has authored many research publications in the field of headaches.
Dr. Goldstein is now directing his focus towards finding treatments for patients affected by Alzheimer’s Disease.
History
Established in 1970.
Dr. Goldstein graduated from the Upstate Medical Center in Syracuse, New York and completed his Neurology residency at the University of California in San Francisco in 1970.
Since completing his residency, Dr. Goldstein has been focusing on treating private patients, as well as conducting clinical trials in the field of headaches and Alzheimer’s Disease.
Meet the Business Owner
Jerome G.
Business Owner
Jerome Goldstein, M.D. is a Board-certified medical neurologist who has a special interest in the diagnosis, treatment, and prevention of headaches.
Dr. Goldstein graduated from the Upstate Medical Center in Syracuse, New York and completed his Neurology residency at the University of California in San Francisco in 1970. He is certified by the American Board of Psychiatry and Neurology and is the Director of the San Francisco Clinical Research Center as well as a member of The American Headache Society, The International Headache Society, and The National Headache Foundation.
Dr. Goldstein has directed research studies on every new 5-HT 1D receptor agonists, including the original pilot studies done on Imitrex® in the United States, including all new prophylactic agents in headache and has authored many research publications in the field of headaches.
Dr. Goldstein is now directing his focus towards finding treatments for patients affected by Alzheimer’s Disease.
Jerome Goldstein MD also recommends
San Francisco Clinical Research Center
Doctors
,
Medical Centers
Jerome G. says,
«Specialists in conducting clinical research for Migraine and Alzheimer’s Disease patients.»